Zertifizierungsrichtlinien für QST-Labore
暂无分享,去创建一个
M. Zenz | T. Tölle | R. Treede | C. Maier | R. Baron | C. Geber | A. Scherens | D. Pfau | N. Nestler | Thomas R. Tölle | Doreen B. Pfau
[1] R. Treede,et al. Habituation and short‐term repeatability of thermal testing in healthy human subjects and patients with chronic non‐neuropathic pain , 2009, European journal of pain.
[2] R. Baron,et al. Painful or painless lower limb dysesthesias are highly predictive of peripheral neuropathy: Comparison of different diagnostic modalities , 2009, European journal of pain.
[3] H. Krämer,et al. Warm and cold complex regional pain syndromes , 2009, Neurology.
[4] Klaus Züchner,et al. Effect of thermode application pressure on thermal threshold detection , 2008, Muscle & nerve.
[5] R. Treede,et al. Detection of a characteristic painful neuropathy in Fabry disease: a pilot study. , 2008, Pain medicine.
[6] G. Wasner,et al. Determinants of thermal pain thresholds in normal subjects , 2008, Clinical Neurophysiology.
[7] P. M. Rossini,et al. Recommendations for the clinical use of somatosensory-evoked potentials , 2008, Clinical Neurophysiology.
[8] S. Azad,et al. Interaction of Hyperalgesia and Sensory Loss in Complex Regional Pain Syndrome Type I (CRPS I) , 2008, PloS one.
[9] R. Treede,et al. Pseudoradicular and radicular low-back pain – A disease continuum rather than different entities? Answers from quantitative sensory testing , 2008, PAIN®.
[10] U. Schlegel,et al. [Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options]. , 2008, Schmerz.
[11] C. Maier,et al. Schmerzhaftes Hyperexzitabilitätssyndrom unter Oxaliplatin-haltiger Chemotherapie , 2007, Der Schmerz.
[12] M. Dieterich,et al. 200 TEST/RETEST‐ AND INTEROBSERVER‐RELIABILITIY IN QUANTITATIVE SENSORY TESTING ACCORDING TO THE PROTOCOL OF THE GERMAN NETWORK ON NEUROPATHIC PAIN (DFNS) , 2007 .
[13] P. M. Lang,et al. Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease , 2006, Pain.
[14] G. Cruccu,et al. Assessment of neuropathic pain , 2006, Neurological Sciences.
[15] F. Birklein,et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values , 2006, PAIN.
[16] G. Cruccu,et al. Pathophysiological mechanisms of neuropathic pain , 2006, Neurological Sciences.
[17] R. Treede,et al. Quantitative sensory testing: a comprehensive protocol for clinical trials , 2006, European journal of pain.
[18] D. Cros,et al. Technology literature review: Quantitative sensory testing , 2004, Muscle & nerve.
[19] B. Arnett. Arnold-Chiari malformation. , 2003, Archives of neurology.
[20] R. D. de Haan,et al. The reliability of assessment of vibration sense , 2003, Acta neurologica Scandinavica.
[21] J C Arezzo,et al. Quantitative sensory testing , 2003, Neurology.
[22] R. Baron,et al. Translation of symptoms and signs into mechanisms in neuropathic pain , 2003, Pain.
[23] R. Freeman,et al. Quantitative sensory testing cannot differentiate simulated sensory loss from sensory neuropathy , 2003, Neurology.
[24] P. Hansson. Neuropathic pain: clinical characteristics and diagnostic workup , 2002, European journal of pain.
[25] C. Woolf,et al. Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.
[26] David Yarnitsky,et al. Heat pain thresholds: normative data and repeatability , 1995, Pain.
[27] David Yarnitsky,et al. Quantitative Sensory Testing , 1992, Diabetes Care.